Objective: Mechanical retrieval of thrombotic material from acute ischemic stroke patients
provides a unique entry point for translational research investigations. Here, we resolved the …

Thrombotic material retrieved from acute ischemic stroke (AIS) patients represents a
valuable source of biological information. In this study, we have developed a clinical …

Background Nowadays little is known about the molecular profile of the occluding thrombus
of patients with ischemic stroke. Objectives To analyze the proteomic profile of thrombi in …

Background and Aims Besides the crucial role in the treatment of acute ischemic stroke
(AIS), mechanical thrombectomy represents a unique opportunity for researchers to study …

Background Stroke is a major cause of death and disability in the United States. Mechanical
thrombectomy (MT) and tissue plasminogen activator are the current treatments for ischemic …

Cerebrovascular diseases represent a leading cause of disability, morbidity, and death
worldwide. In the last decade, the advances in endovascular procedures have not only …

Background Since 2015, mechanical thrombectomy has been the standard treatment for
emergent large vessel occlusion ischemic stroke. Objective To investigate, using the …

Introduction The specific protein composition of stroke-causing emboli is unknown. Because
ischemic stroke has a varied etiology, it is possible that the composition of the thrombus from …

Ischemic stroke is caused by blood clot formation and consequent vessel blockage.
Proteomic approaches provide a cost-effective alternative to current diagnostic methods …

Stroke has a high incidence rate and often leads to permanent disability, particularly if it is
not treated promptly. However, no blood biomarkers for early diagnosis are available to …